Recombinant multi-species APC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
The Alternative Names of target: APC,Adenomatous polyposis coli protein,Apc,BTPS2,CC1,DESMD,DP2,DP2.5,DP3,Deleted in polyposis 2.5,GS,Min,PPP1R46,Protein APC,RATAPC,mAPC
Go
to APC products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP8023-Ag-1/ GM-Tg-hg-IP8023-Ag-2 | Human APC protein | Human |
| GM-Tg-rg-IP8023-Ag-1/ GM-Tg-rg-IP8023-Ag-2 | Rat APC protein | Rat |
| GM-Tg-mg-IP8023-Ag-1/ GM-Tg-mg-IP8023-Ag-2 | Mouse APC protein | Mouse |
| GM-Tg-cynog-IP8023-Ag-1/ GM-Tg-cynog-IP8023-Ag-2 | Cynomolgus/Rhesus macaque APC protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP8023-Ag-1/ GM-Tg-felg-IP8023-Ag-2 | Feline APC protein | Feline |
| GM-Tg-cang-IP8023-Ag-1/ GM-Tg-cang-IP8023-Ag-2 | Canine APC protein | Canine |
| GM-Tg-bovg-IP8023-Ag-1/ GM-Tg-bovg-IP8023-Ag-2 | Bovine APC protein | Bovine |
| GM-Tg-equg-IP8023-Ag-1/ GM-Tg-equg-IP8023-Ag-2 | Equine APC protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP8023-Ag-1/ GM-Tg-hg-IP8023-Ag-2;
GM-Tg-rg-IP8023-Ag-1/ GM-Tg-rg-IP8023-Ag-2;
GM-Tg-mg-IP8023-Ag-1/ GM-Tg-mg-IP8023-Ag-2; GM-Tg-cynog-IP8023-Ag-1/ GM-Tg-cynog-IP8023-Ag-2; GM-Tg-felg-IP8023-Ag-1/ GM-Tg-felg-IP8023-Ag-2; GM-Tg-cang-IP8023-Ag-1/ GM-Tg-cang-IP8023-Ag-2; GM-Tg-bovg-IP8023-Ag-1/ GM-Tg-bovg-IP8023-Ag-2; GM-Tg-equg-IP8023-Ag-1/ GM-Tg-equg-IP8023-Ag-2 |
| Products Name | APC protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | APC |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APC protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.